IBO Annual Cash & Cash Equivalents
$1000.00
-$1000.00-50.00%
01 December 2023
Summary:
As of February 3, 2025, IBO annual cash & cash equivalents is $1000.00, with the most recent change of -$1000.00 (-50.00%) on December 1, 2023. During the last 3 years, it has fallen by -$71.30 thousand (-98.62%). IBO annual cash & cash equivalents is now -99.08% below its all-time high of $108.70 thousand, reached on December 1, 2019.IBO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IBO Quarterly Cash And Cash Equivalents
$2.67 M
+$2.67 M+133300.00%
01 September 2024
Summary:
As of February 3, 2025, IBO quarterly cash and cash equivalents is $2.67 million, with the most recent change of +$2.67 million (+133300.00%) on September 1, 2024. Over the past year, it has increased by +$2.67 million (+133300.00%). IBO quarterly cash and cash equivalents is now at all-time high.IBO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IBO Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -50.0% | +10000.0% |
| 3 y3 years | -98.6% | - |
| 5 y5 years | -99.1% | - |
IBO Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -97.8% | at low | at high | >+9999.0% |
| 5 y | 5-year | -99.1% | at low | at high | >+9999.0% |
| alltime | all time | -99.1% | at low | at high | >+9999.0% |
Impact BioMedical Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.67 M(>+9900.0%) |
| June 2024 | - | $2000.00(0.0%) |
| Mar 2024 | - | $2000.00(+100.0%) |
| Dec 2023 | $1000.00(-50.0%) | $1000.00(-99.5%) |
| Sept 2023 | - | $201.00 K(+6600.0%) |
| June 2023 | - | $3000.00(+200.0%) |
| Mar 2023 | - | $1000.00(-50.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $2000.00(-95.7%) | $2000.00(-98.0%) |
| Sept 2022 | - | $101.00 K(+206.1%) |
| Mar 2022 | - | $33.00 K(-28.3%) |
| Dec 2021 | $46.00 K(-36.4%) | $46.00 K(-37.2%) |
| June 2021 | - | $73.30 K(+1.4%) |
| Dec 2020 | $72.30 K(-33.5%) | $72.30 K(-0.1%) |
| Sept 2020 | - | $72.40 K(-33.4%) |
| Dec 2019 | $108.70 K | $108.70 K |
FAQ
- What is Impact BioMedical annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Impact BioMedical?
- What is Impact BioMedical annual cash & cash equivalents year-on-year change?
- What is Impact BioMedical quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Impact BioMedical?
- What is Impact BioMedical quarterly cash and cash equivalents year-on-year change?
What is Impact BioMedical annual cash & cash equivalents?
The current annual cash & cash equivalents of IBO is $1000.00
What is the all time high annual cash & cash equivalents for Impact BioMedical?
Impact BioMedical all-time high annual cash & cash equivalents is $108.70 K
What is Impact BioMedical annual cash & cash equivalents year-on-year change?
Over the past year, IBO annual cash & cash equivalents has changed by -$1000.00 (-50.00%)
What is Impact BioMedical quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of IBO is $2.67 M
What is the all time high quarterly cash and cash equivalents for Impact BioMedical?
Impact BioMedical all-time high quarterly cash and cash equivalents is $2.67 M
What is Impact BioMedical quarterly cash and cash equivalents year-on-year change?
Over the past year, IBO quarterly cash and cash equivalents has changed by +$2.67 M (+133300.00%)